Related Experiment Video
Updated: Jun 17, 2025

06:47
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
9.7K
Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Celina Borges Migliavaca1,2,3, Rosana Lazzarini4, Cinara Stein1,2
1From the HTA Unit, Inova Medical, Porto Alegre, Brazil.
Dermatitis : Contact, Atopic, Occupational, Drug
|August 12, 2024
Summary
Atopic dermatitis (AD) affects 11.1% of children and 6.3% of adults globally. This study quantifies the worldwide prevalence of AD and its severe forms, informing healthcare policies and research.
Area of Science:
- Epidemiology
- Dermatology
- Public Health
Background:
- Atopic dermatitis (AD) significantly impacts quality of life and incurs substantial healthcare costs.
- Understanding the global burden of AD is crucial for effective resource allocation and intervention strategies.
Purpose of the Study:
- To estimate the worldwide point prevalence of atopic dermatitis (AD).
- To determine the global proportion of severe AD cases.
- To explore heterogeneity in prevalence and severity estimates.
Main Methods:
- Systematic literature search of MEDLINE, Embase, and Global Index Medicus (2012-2022).
- Inclusion of 310 primary prevalence studies encompassing over 25.5 million individuals.
- Random-effects meta-analyses and subgroup analyses to pool and evaluate prevalence data.
Main Results:
- Global point prevalence of AD was 11.1% in children/adolescents and 6.3% in adults (moderate certainty).
- Proportion of severe AD cases ranged from 1.9% to 7.2% in younger populations and 2.8% to 15.6% in adults.
- Prevalence estimates remained consistent across studies with low risk of bias.
Conclusions:
- This comprehensive analysis provides robust estimates of global AD prevalence and severity.
- Findings can inform public health policies, guide research priorities, and support clinical decision-making for AD management.
More Related Videos
Related Concept Videos
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Allergic Reactions
27.3K
Overview
27.3K

